#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>Negative
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>The clinical efficacy of the carbapenems has not been established for treating infections caused by Enterobacteriaceae that test as carbapenem susceptible (CLSI M100-S20 MIC breakpoints: ertapenem less than or equal to 2 µg/mL, imipenem less than or equal to 4 µg/mL, and/or meropenem less than or equal to 4 µg/mL) but demonstrate carbapenemase production in vitro.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
An additional handling fee will be billed for all organisms submitted that are not in pure culture as indicated in the specimen requirements.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
87184
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Hodge Test (Antimicrobial Susceptibility - Carbapenem Resistance) |
*ExistCrossReferences>